Edition:
United States

BIOLASE Inc (BIOL.OQ)

BIOL.OQ on NASDAQ Stock Exchange Capital Market

1.29USD
24 Mar 2017
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.29
Open
$1.25
Day's High
$1.29
Day's Low
$1.25
Volume
6,239
Avg. Vol
24,280
52-wk High
$1.97
52-wk Low
$0.86

Latest Key Developments (Source: Significant Developments)

Biolase Q4 loss per share $0.07
Wednesday, 8 Mar 2017 04:05pm EST 

Biolase Inc : Biolase reports 2016 full year and fourth quarter results . Q4 revenue fell 5 percent to $13.8 million . Q4 loss per share $0.07 .Biolase Inc says net revenue for Q4 of 2016 was $13.8 million, as compared to net revenue of $14.5 million for Q4 of 2015.  Full Article

BIOLASE announces management change
Monday, 9 Jan 2017 06:00am EST 

BIOLASE Inc : BIOLASE announces management change . BIOLASE Inc - senior vice president and chief financial officer David C. Dreyer has decided to resign effective January 13, 2017 . BIOLASE Inc - company is conducting a search for a new chief financial officer .BIOLASE - until replacement is named, dreyer's day to day finance responsibilities will be handled by Harold C. Flynn, Jr..  Full Article

Biolase files for resale of up to 10.9 mln shares by selling stockholders
Thursday, 27 Oct 2016 04:05pm EDT 

Biolase Inc : Files for resale of up to 10.9 million shares of co's common stock, by the selling stockholders - SEC filing Source: http://bit.ly/2e1V784 Further company coverage: [BIOL.O] ((Bangalore.newsroom@thomsonreuters.com;)).  Full Article

Biolase Q2 loss per share $0.06
Monday, 1 Aug 2016 06:10am EDT 

Biolase Inc : Biolase Reports 2016 Second Quarter And Six-Month results . Q2 revenue rose 16 percent to $13.8 million .Q2 loss per share $0.06.  Full Article

Biolase to raise $10 mln in convertible preferred private placement
Monday, 1 Aug 2016 06:00am EDT 

Biolase Inc : Biolase to raise $10 million from institutional and individual investors in convertible preferred private placement .Has agreed to sell an aggregate of 88,494 shares of its convertible preferred stock at a per share price of $113.00.  Full Article

Biolase reports Q1 loss per share $0.07
Monday, 9 May 2016 04:05pm EDT 

Biolase Inc : Biolase reports 2016 first quarter results . Q1 loss per share $0.07 .Q1 revenue rose 1.4 percent to $11 million.  Full Article

Biolase Inc enters into development agreement with IPG Photonics
Tuesday, 12 Jan 2016 04:05pm EST 

Biolase Inc:Announces that it recently entered into a development and distribution agreement with IPG Photonics Corporation's medical laser division, IPG Medical.  Full Article

BIOLASE Inc announces management changes
Monday, 18 May 2015 04:30pm EDT 

BIOLASE Inc:Says Harold C. Flynn to become President and CEO, effective July 13.Says current President and CEO Jeffrey M. Nugent will step down on July 13.  Full Article

More From Around the Web

BRIEF-Biolase announces the FDA clearance and worldwide launch of its new Epic Pro diode laser system

* Biolase announces the FDA clearance and worldwide launch of its new Epic Pro(tm) diode laser system